Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

66.1K
Overview
66.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.3K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

650
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

863
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
863
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.

BMC medicine·2020
Same author

Atherogenesis and inflammation. From cellular mediators to regulatory mechanisms of inflammation in atherosclerosis.

Hamostaseologie·2015
Same author

microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans.

Thrombosis and haemostasis·2012
Same author

Differential role of monocyte subsets in atherosclerosis.

Thrombosis and haemostasis·2011
Same author

Progenitor cell trafficking in the vascular wall.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Analog implementation of ANN with inherent quadratic nonlinearity of the synapses.

IEEE transactions on neural networks·2008
Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026
Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

14.1K

Monocyte subsets in atherosclerosis.

M Hristov1, G H Heine

  • 1PD Dr. med. Michael Hristov, IPEK, LMU München, Pettenkoferstr. 9, 80336 München, Tel. +49/(0)89/440 05 43 -71 Fax -82,

Hamostaseologie
|November 15, 2014
PubMed
Summary
This summary is machine-generated.

Monocyte heterogeneity is key in atherosclerosis. Different monocyte subsets (classical, intermediate, nonclassical) play distinct roles in arterial wall inflammation and lesion development, influencing cardiovascular disease progression.

Keywords:
Leukocytescoronary artery diseaseobesityrecruitmentsmoking

More Related Videos

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
09:12

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis

Published on: October 17, 2018

59.6K
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.7K

Related Experiment Videos

Last Updated: Apr 20, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

14.1K
Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
09:12

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis

Published on: October 17, 2018

59.6K
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.7K

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • Atherosclerosis development is driven by endothelial dysfunction and arterial wall inflammation.
  • Monocytes, crucial innate immune cells, are significantly implicated in atherosclerotic lesion progression.
  • Recent research highlights the heterogeneity of circulating monocytes, with a consensus nomenclature defining classical, intermediate, and nonclassical subsets.

Purpose of the Study:

  • To review recent findings on human and mouse monocyte subpopulations in atherosclerosis.
  • To detail the differential contribution of monocyte subsets to atherosclerotic vascular disease.
  • To examine monocyte phenotype, function, and recruitment mechanisms in homeostasis, atherosclerosis, and acute myocardial infarction.

Main Methods:

  • Literature review of experimental and clinical data.
  • Analysis of studies focusing on monocyte subset characterization.
  • Synthesis of findings on monocyte recruitment and function in cardiovascular contexts.

Main Results:

  • Circulating monocytes exhibit significant heterogeneity, with distinct subsets.
  • Each monocyte subset (classical, intermediate, nonclassical) displays unique phenotypes and functions.
  • These subsets are differentially recruited and contribute specifically to atherosclerosis and myocardial infarction pathology.

Conclusions:

  • Monocyte subset heterogeneity is a critical factor in the pathogenesis of atherosclerosis.
  • Understanding these specific roles is vital for developing targeted therapies for atherosclerotic vascular disease.
  • Further research into monocyte subset dynamics can illuminate mechanisms of cardiovascular injury and repair.